Ariëns E J, Simonis A M
Biochem Pharmacol. 1983 May 15;32(10):1539-45. doi: 10.1016/0006-2952(83)90324-6.
The questions raised are: what is the physiological or pharmacological basis for the differentiation into beta 1- and beta 2-, and alpha 1- and alpha 2-adrenergic receptors?; and do the neurotransmitter norepinephrine and the hormone epinephrine differ in their receptors? On the basis of a preference of beta 2- and alpha 2-adrenergic receptors for epinephrine, the hormone, and of beta 1-and alpha 1-receptors for norepinephrine, the neurotransmitter, it was postulated that the alpha 2- and beta 2-receptors are predominantly epinephrinergic in nature and located extrajunctionally and presynaptically whereas the alpha 1- and beta 1-receptors are predominantly norepinephrinergic in nature and located postsynaptically in the sympathetic terminal junction. The alpha 2- and beta 2-character of the presynaptic receptors matches that of the corresponding extrajunctional receptors. This indicates that a circulating catecholamine, namely epinephrine, is involved in the regulation of adrenergic transmitter release.
分化为β1和β2以及α1和α2肾上腺素能受体的生理或药理学基础是什么?神经递质去甲肾上腺素和激素肾上腺素在其受体方面是否存在差异?基于β2和α2肾上腺素能受体对激素肾上腺素的偏好,以及β1和α1受体对神经递质去甲肾上腺素的偏好,有人推测α2和β2受体本质上主要是肾上腺素能的,位于接头外和突触前,而α1和β1受体本质上主要是去甲肾上腺素能的,位于交感神经终末接头的突触后。突触前受体的α2和β2特性与相应的接头外受体相匹配。这表明循环中的儿茶酚胺,即肾上腺素,参与了肾上腺素能递质释放的调节。